Bristol, UK, 10th December, 2025 - Neurotechnology company Neupulse has announced a first-of-its-kind wearable device proven to dramatically reduce the frequency and urge of tics in people living with ...
Neupulse has secured funding to advance the world's first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialization. Neupulse's recently finalised ...
Two technologies that are based on research by University of Nottingham experts to reduce the severity of tics in people with Tourette syndrome (TS) are closer to patient use after being recommended ...
Insider has profiled some of the most promising spin-outs from Midlands universities, with businesses developing innovative technology that accelerates recovery from surgery, alleviates the symptoms ...
Lewis Capaldi visited the researchers ahead of his gig in Nottingham Lewis Capaldi invited a team of university researchers to a gig after testing a device aimed at reducing tics in those with ...
Add Yahoo as a preferred source to see more of our stories on Google. A wrist device for people with Tourette's syndrome has been described as "life-changing". The Neupulse aims to reduce the symptoms ...
The National Institute for Health and Care Excellence (NICE) has approved two technologies for treating chronic tic disorders and Tourette syndrome. The Online Remote Behavioural Intervention for Tics ...
NICE's medical technologies advisory committee considered evidence on digital therapy for chronic tic disorders and Tourette syndrome from several sources, including an early value assessment report ...
Table 1 summarises the evidence gaps and ongoing studies that might address them. Information about evidence status is derived from the external assessment group's (EAG) report; evidence not meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results